Канал: Springer Healthcare IME - Смотреть видео c канала или скачать видео c канала в MP4, музыку MP3 на телефон или компьютер.

$precision medicine advances in thyroid cancer – Management of advanced rai refractory$

Enhancing safety and efficacy in amyloid-targeted therapies

Springer Healthcare IME

Springer Healthcare IME

Enhancing safety and efficacy in amyloid-targeted therapies

Representation in clinical trials and implementation of blood-based biomarkers

PET tracers: Which, who and how? - Lyduine Collij

Advances in AD PET biomarkers - Alexander Drzezga

Role of PET imaging in the disease modification era of Alzheimer's disease Silvia Morbelli

Introduction - Frederik Barkhof

CTAD – Breakfast Bite - Claire Paquet discusses the implications of the real-world

CTAD – Juan Fortea comments on future opportunities for anti-amyloid antibody treatment

Video shots | Highlights and latest updates from ESMO 2024

Video shots | Highlights and latest content on ESMO 2024

Video shots | Highlights and updates from ESMO 2024

Speed-meet the Multidisciplinary Team: Hematologist

Amyloidosis Center Success Story - Pavia, Italy

Speed-meet the Multidisciplinary Team: Cardiologist

Experts in Conversation: Highlights from AAIC

CGM Updates and Highlights from EASD 2024

Amyloidosis Centre Success Story

Speed meet our multidisciplinary team - Christine Chiti

ASCO24 Highlights: Advances in NSCLC

AAIC – Is it too soon to use blood-based biomarkers for AD in primary care?

AAIC - Discussing the potential for blood-based biomarker use

Enhancing Diabetes Management:Clinician-Patient Collaboration on Continuous Glucose Monitoring (CGM)

ADPD 2024™: Earlier treatment with anti-amyloid immunotherapies - Podcast to Practice S1E2

CONY 2024: Sleep disturbance as a risk factor for Alzheimer's Disease - Podcast to Practice S1E3

CONY 2024: Comments on Lecanemab treatment extension beyond 18 months - Podcast to Practice S1E4

Continuous Glucose Monitoring Updates and Highlights from ATTD 2024 - Podcast to Practice S3E1

Continuous Glucose Monitoring Updates and Highlights from ADA 2024 - Podcast to Practice S3E2

Overview of the diabetes-cardio-kidney spectrum and importance of proactive management | S5E1

AAIC Conference – Breakfast Bite 7 – The effects of time on blood-based biomarkers

Targeted therapy for ALK-positive NSCLC: A practical case study | Biomarker-guided therapy in NSC...

Navigating NSCLC: Merging molecular insights and targeted therapy | Biomarker-guided therapy in N...

Optimal approaches for resectable ALK-driven NSCLC | Biomarker-guided therapy in NSCLC and beyond...

Improving recognition, diagnosis and classification of CKD in T2D | S5E2

Improving integration of guidelines for CKD in T2D in clinical practice | S5E3

Advances in therapies that work across multiple disease disciplines | S5E4

Optimizing care for patients with mUC

The expanding treatment landscape | Important conversations on key mUC developments

Advancements in Tumor-Agnostic Cancer Treatment: Expert Panel Discussion

New Frontiers in Oncology: Advanced Diagnostics and Therapeutics | Dr. Solange Peters

The Era of Precision Oncology | Dr. Jaime L. Schneider

Evolving Landscape of Targeted Therapies | Dr. Lizza Hendriks

Journey to a New Era for Alzheimer's Disease - Introduction to the Program

CGM Updates and Highlights from ADA 2024

CGM Updates and Highlights from ATTD 2024

Biomarker-Positive Disease: Approach to Selecting Targeted Therapies in Lung Cancer and Beyond.

Experts in Conversation: Highlights from AD/PD and CONy

Chapter 4 - How can we work together to expand the global center network: Q&A

Full webcast

Chapter 3: Exploring the advantages and challenges of establishing additional amyloidosis centers

Chapter 2: Unmet needs in amyloidosis diagnosis and care - Vaishali Sanchorawala

Amyloidosis Action: Chapter 1 - Introduction with Marianna Fontana

Comments on the debate over whether lecanemab should be extended beyond 18 months - Zvezdan Pirtosek

CONy – Breakfast Bite 3 – Sleep disturbance as a risk factor for AD - Lea Grinberg

AD/PD™️ 2024 – Highlights research on earlier treatment with anti-amyloid immunotherapies

AD/PD™️ 2024 – Breakfast Bite – Highlights of latest research on fluid biomarkers

Coping with Primary biliary cholangitis (PBC): treatment challenges and QoL insights

The evolving treatment landscape of hemophilia - Professor Johnny Mahlangu

Updates on diagnosis and monitoring of treatment responses - Professor Margareth Ozelo

One size does NOT fit all with Professor David Lillicrap, Dr Víctor Jimenez-Yuste and patient

Combination therapies and real world treatment for PBC patients - Adriaan van der Meer

Breaking analysis of ASSURE from EASL 2024 - Marc Swain

ELATIVE updates from EASL 2024 - Marco Carbone

Independent symposium at the 10th World Congress on Controversies in Multiple Myeloma (COMy)

Walking the path of Primary Biliary Cholangitis (PBC): navigating symptoms and QoL

The evolving landscape of Primary Biliary Cholangitis (PBC): new therapies and future directions

ADPD 2024™: Highlights of latest research on fluid biomarkers - Podcast to Practice S1E1

The analysis of breakthrough research on Primary Biliary Cholangitis (PBC) with Kris Kowdley

CKD in primary care: early identification and intervention for improved outcomes

How can primary care be supported to bridge the chronic kidney disease (CKD) gap?

Management of chronic kidney disease (CKD) in primary care: a patient journey

Identification and stratification of chronic kidney disease (CKD) in primary care: a patient journey

The burden of chronic kidney disease (CKD) in primary care

Submit your questions

What to expect from this program | Welcome video

Long term safety of targeted therapies

Timing the initiation of systemic therapy

How to select a first-line treatment